Journal: Scientific reports
Article Title: Blockade of CXXC5-dishevelled interaction inhibits adipogenic differentiation, obesity, and insulin resistance in mice.
doi: 10.1038/s41598-022-25315-x
Figure Lengend Snippet: Figure 2. KY19334 treatment prevents diet-induced obesity and insulin resistance. C57BL/6 mice fed the NCD or HFD were orally administered with KY19334 or Orlistat concentration at 25 mg/kg/day for 8 weeks (n = 6 per group). (A) Representative photographs (upper panel) and MR images of mice (lower panel). Visceral and subcutaneous fat were quantified (B) Body weight changes. (C) Body weight gain (D) Daily food intake during all study weeks (mean ± SD., n.s indicates non-significance with HFD-fed vehicle group). (E) Plasma concentration of total cholesterol, HDL-cholesterol, leptin, and resistin in the overnight fasted state. (F) Fasting glucose. (G) Glucose and insulin tolerance test. Scale bar, 100 µm. Results are expressed as mean ± SD., n = 3 per group, *P < 0.05, ***P < 0.001, n.s indicates non-significance with HFD-fed vehicle group. NCD normal chow diet, HFD high-fat diet.
Article Snippet: ELISA assay kits were used to assess serum leptin (R&D system, MOB00B), serum resistin (R&D system, MRSN00), serum FFA (Cayman Chemical, 700310).
Techniques: Concentration Assay, Clinical Proteomics